Not Yet Recruiting OBSERVATIONAL NCT07234838

Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO) (CONDYPSO)

Influence of Anti-Psoriatic Biologic Therapies Targeting TNF-α and Interleukins 17 and 23 on the Risk of Development and Recurrence of Anogenital Warts: A Retrospective and Prospective Study With an Exploratory Component on HPV Vaccination Acceptability (CONDYPSO)

Sponsor: Jonathan Krygier

Conditions Biotherapies Condyloma Acuminata Psoriasis

Updated 1 time since 2025 Last updated: Nov 14, 2025 Started: Dec 1, 2025 Primary completion: May 1, 2028 Completion: May 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07234838, this observational or N/A phase trial focuses on Biotherapies and Condyloma Acuminata and remains actively recruiting participants. Sponsored by Jonathan Krygier, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jonathan Krygier

Data source: Centre Hospitalier Universitaire Saint Pierre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium